CRP and COVID-19: Besides CRP apheresis, approaches aimed at inhibiting either CRP dissociation into mCRP (34, 35) or antibodies against mCRP (36) could represent attractive alternatives to prevent the cytokine storm and hyperinflammatory status associated to COVID-19.